Education
About Us
Working with TipRanks
Follow Us
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
VSBC Stock Chart & Stats
$0.25
$0.00(0.00%)
At close: 4:00 PM EST
$0.25
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.15 - $1.00
Previous CloseN/A
Volume42.00
Average Volume (3M)0.00
Market Cap
$51.78M
Enterprise Value$207.26M
Total Cash (Recent Filing)$24.05K
Total Debt (Recent Filing)$329.63K
Price to Earnings (P/E)―
Beta-2.88
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding207,030,030
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.72
Price to Book (P/B)-1.29K
Price to Sales (P/S)0.00
P/FCF Ratio-39.75K
Enterprise Value/Market Cap4.00
Enterprise Value/Revenue41.63
Enterprise Value/Gross Profit102.04
Enterprise Value/Ebitda174.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VitaSpring Biomedical News
VSBC FAQ
What was VitaSpring Biomedical’s price range in the past 12 months?
VitaSpring Biomedical lowest stock price was $0.15 and its highest was $1.00 in the past 12 months.
What is VitaSpring Biomedical’s market cap?
VitaSpring Biomedical’s market cap is $51.78M.
When is VitaSpring Biomedical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were VitaSpring Biomedical’s earnings last quarter?
Currently, no data Available
Is VitaSpring Biomedical overvalued?
According to Wall Street analysts VitaSpring Biomedical’s price is currently Overvalued.
Does VitaSpring Biomedical pay dividends?
VitaSpring Biomedical does not currently pay dividends.
What is VitaSpring Biomedical’s EPS estimate?
VitaSpring Biomedical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VitaSpring Biomedical have?
VitaSpring Biomedical has 207,030,030 shares outstanding.
What happened to VitaSpring Biomedical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VitaSpring Biomedical?
Currently, no hedge funds are holding shares in VSBC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VitaSpring Biomedical
VitaSpring Biomedical Co. Ltd. focuses on the development of drugs of cell medicine. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is headquartered in Irvine, California.
Technical Analysis
―
Silence Therapeutics
―
OmniAb
―
Entrada Therapeutics Inc
―
Sagimet Biosciences, Inc. Class A
―